BioSpace News Archive

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, announced that President and CEO Athena Countouriotis, M.D., will participate in the Jefferies 2019 London Healthcare Conference on Nov. 20 and Piper Jaffray’s 31st Annual Healthcare Conference in New York on Dec. 4.

InsightRX, a pioneer in precision medicine, and Premier Inc., a healthcare improvement company uniting 4,000 U.S. hospitals and health systems, have joined forces to individualize medication dosing for drugs used to treat infectious disease.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will participate as a gold sponsor at the Cervical Spine Research Society (CSRS) 47th Annual Meeting, November 21-23, 2019 at the New York Marriott Marquis in New York City.

Cerus Corporation (Nasdaq:CERS) announced today that Kevin D. Green, Cerus’ chief financial officer, will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at 2:25 p.m. ET in New York City.

The study is sponsored by Neurocrine Biosciences and conducted in collaboration with the Huntington Study Group.

eMDs announced today that it has broadened its relationship with DrFirst, one of the nation’s leading providers of e-prescribing, patient medication management and price transparency solutions, to deliver new consumer-facing medication adherence solutions to healthcare providers through eMDs Prescribe, eMDs’ e-prescribing system.

In an effort to help clinicians stay current with the latest advancements in medical imaging, Canon Medical Systems, USA, through an unrestricted educational grant, invites you to expert-led forums at this year’s Radiological Society of North America (RSNA) annual meeting, December 1-7, 2019 in Chicago, IL

Built for clinical operations professionals by clinical operations professionals, SureClinical today announced the launch and availability of its Spring 2019 Suite for ClinOps™.

CareCentrix, the leading provider of in home-based post-acute-care solutions, put out a statement today in support of CT2030, Connecticut Governor Ned Lamont’s comprehensive transportation infrastructure plan.

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, today announced that Dr. Christian Itin, chairman and chief executive officer, will present at the Jefferies 2019 London Healthcare Conference on Wednesday, November 20, 2019 at 10:40 am GMT in London, UK.